Ketoacidosis caution for diabetes drug

The TGA is urging doctors to be vigilant for diabetic ketoacidosis in patients taking the class of drugs that are inhibitors of sodium glucose co-transporter (SGLT2 inhibitors).

The advisory notice issued on Thursday applies to drugs such as dapagliflozin (Forxiga, Xigduo XR), canagliflozin (Invokana) and empagliflozin (Jardiance) for type 2 diabetes,.

It follows US reports of serious cases of diabetic ketoacidosis in patients taking the drugs.

Related News

Latest

Trending